A Single-Dose, Open-Label, Randomized, 2-Period Crossover Study to Assess the Effect of Food Coadministration on the Pharmacokinetics of a Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 29 Dec 2014
At a glance
- Drugs Canagliflozin/metformin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- 26 Mar 2012 Company added in association field as reported by ClinicalTrials.gov.
- 23 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Dec 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.